Sumitomo Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Ehime Japan (1986)
Status: Acquired by Sumitomo Dainippon (2005)

Organization Overview

First Clinical Trial
2008
NCT00660504
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Sumitomo Pharmaceuticals America | Sumitomo Pharmaceutical (Suzhou) Co., Ltd. | Sumitomo Pharma Co., Ltd.